NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
ELEVAR THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
68
Latest update
11/26/2024
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
09/16/2019
Registration date
11/26/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/16/2019
First use in commerce
10/16/2019
Drawing code
3
Owner type
03
Owner location
Salt Lake City, UT, US
Examiner
GARDNER, DAWNA BERYL
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized blue lowercase wording "ELEVAR" above the stylized gray lowercase wording "THERAPEUTICS". Above the letters "A" and "R" in "ELEVAR" is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.
Holders and representatives
Holders
Elevar Therapeutics, Inc.
Representatives
Cynthia Walden Fish & Richardson P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments
Publications
History of USPTO decisions and trademark events.
68 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/16/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/15/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/14/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/23/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/22/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
12/22/2023
IUAF
USE AMENDMENT FILED
12/13/2023
DRRR
DIVISIONAL REQUEST RECEIVED
12/13/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/13/2023
EISU
TEAS STATEMENT OF USE RECEIVED
12/13/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/09/2023
EX4G
SOU EXTENSION 4 GRANTED
06/07/2023
EXT4
SOU EXTENSION 4 FILED
06/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2022
EX3G
SOU EXTENSION 3 GRANTED
12/08/2022
EXT3
SOU EXTENSION 3 FILED
12/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/17/2022
EX2G
SOU EXTENSION 2 GRANTED
06/15/2022
EXT2
SOU EXTENSION 2 FILED
06/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/15/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2021
EX1G
SOU EXTENSION 1 GRANTED
12/15/2021
EXT1
SOU EXTENSION 1 FILED
12/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/19/2021
GNRT
NON-FINAL ACTION E-MAILED
01/19/2021
CNRT
NON-FINAL ACTION WRITTEN
01/19/2021
EXPT
EXPARTE APPEAL TERMINATED
01/16/2021
ZZAX
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
01/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2020
EXPI
EX PARTE APPEAL-INSTITUTED
12/17/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/17/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
12/17/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/16/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/16/2020
GNFR
FINAL REFUSAL E-MAILED
06/16/2020
CNFR
FINAL REFUSAL WRITTEN
06/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2020
ALIE
ASSIGNED TO LIE
05/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2019
GNRT
NON-FINAL ACTION E-MAILED
11/15/2019
CNRT
NON-FINAL ACTION WRITTEN
11/15/2019
DOCK
ASSIGNED TO EXAMINER
11/12/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2019
NWAP
NEW APPLICATION ENTERED
09/19/2019
Continuous trademark protection
Get notified about every new filing that threatens ELEVAR THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.